ISSUE

Merck, the World’s Oldest Global Pharmaceutical
Company, Completed Construction of Korea Life Science Operation Center

Mutual Growth through Enhancing Capacity in Domestic Bio Sector Expected

 

Merck Ltd. Korea, a subsidiary of German multinational company Merck Group, completed the construction of Korea Life Science Operation Center (one basement floor, five ground floors) in a 10,141㎡ site in the Bio Cluster of Songdo International City. This Center is the 2nd phase of the facility investment of Merck, following M Lab™ Collaboration Center, established in October 2016 in Songdo International City. The total expense for the project, KRW 26 billion, was invested from Merck. The company implemented the project to integrate the businesses in the Life Science sector, which is decentralized in Korea, and to manufacture and supply the cell culture medium, a crucial material for biomedicine.
The cell culture medium that will be manufactured and supplied from the Korea Life Science Operation Center is an item mentioned in the government’s strategy for bio health industry innovation, announced in May 2019, as an essential material that needs technology development. R&D and secure capacity for stable domestic supply are vital. Therefore, the construction of Korea Life Science Operation Center of Merck is expected to contribute to the enhancement of the capacity for domestic bio process based on domestic manufacturing and supply of cell culture medium.

 

The IFEZ commissioner Lee Won-jae said, “Songdo International City is a global city where the leading companies in the bio process sector, such as Merck, are located. It is now emerging as a core region to foster”Not only global companies, but also venture companies and SMEs, will move into the city so that it would become a leading cluster that realizes the mutual growth in the bio sector. To this end, I will spare no support.”
Established in Germany in 1668, Merck is the oldest global pharmaceutical company with 351 years of history. In addition, the company is a science and technology company that supplies various goods and services in the chemical and bio sector. In particular, in the bio science sector, it provides R&D, related products, and technological services to a number of bio companies in Korea. the back and front industries of the bio sector.” He added,”Not only global companies, but also venture companies and SMEs, will move into the city so that it would become a leading cluster that realizes the mutual growth in the bio sector. To this end, I will spare no support.”
Established in Germany in 1668, Merck is the oldest global pharmaceutical company with 351 years of history. In addition, the company is a science and technology company that supplies various goods and services in the chemical and bio sector. In particular, in the bio science sector, it provides R&D, related products, and technological services to a number of bio companies in Korea.

Merck M. Lab Collaboration Center

[Company Introduction]

Merck KGaA

– The world’s oldest global pharmaceutical company established in Germany, in 1668
– Global company specialized in science, such as pharmaceuticals, bio science, functional material, etc.
– Operated in 250 companies in 66 countries with approximately 51,713 employees
– Revenue: EUR 14.1 billion (as of 2018, approximately KRW 19 trillion)

[Project Introduction]

Construction of Korea Life Science Operation Center of Merck Ltd. Korea

– Location: Bio Cluster, Songdo International City
– Area: 10,141㎡
– Scope: One basement floor and five ground floors
– Constructor: Merck Ltd. Korea
– Major Businesses: Manufacturing and supplying cell culture medium, integrating businesses in Life Science sector, etc.

Merck Ltd. Korea to hold Open Innovation Program with Korean Companies

Merck Ltd. Korea is to hold an open innovation programs with Korean companies by co-developing new drugs. Merck Ltd. Korea announced the open innovation program for Korean startups at the 2019 EU-Korea Open Innovation Day, hosted by KOTRA and Korea Institute of Startup and Entrepreneurship Development. Implemented in Germany and China at the same time, the program connects not only Merck’s innovation program but also three core business sectors with startups with the aim to generate joint business development and sustainable partnership. Through the program, Merck plans to support research on health care, bio science, functional material, bio interface technology, liquid biopsy, AI-based new drug R&D, and digital therapeutics.